000 01340 a2200409 4500
005 20250512215402.0
264 0 _c19841114
008 198411s 0 0 eng d
022 _a0041-008X
024 7 _a10.1016/0041-008x(84)90032-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWebb, D R
245 0 0 _aIn vitro solubility and in vivo toxicity of gallium arsenide.
_h[electronic resource]
260 _bToxicology and applied pharmacology
_cOct 1984
300 _a96-104 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aArsenic
_xadverse effects
650 0 4 _aArsenic Trioxide
650 0 4 _aArsenicals
650 0 4 _aBody Weight
_xdrug effects
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFeces
_xanalysis
650 0 4 _aGallium
_xadverse effects
650 0 4 _aLung
_xdrug effects
650 0 4 _aMale
650 0 4 _aOrgan Size
_xdrug effects
650 0 4 _aOxides
650 0 4 _aPorphyrins
_xurine
650 0 4 _aRats
650 0 4 _aRats, Inbred F344
650 0 4 _aSolubility
700 1 _aSipes, I G
700 1 _aCarter, D E
773 0 _tToxicology and applied pharmacology
_gvol. 76
_gno. 1
_gp. 96-104
856 4 0 _uhttps://doi.org/10.1016/0041-008x(84)90032-2
_zAvailable from publisher's website
999 _c6484876
_d6484876